Cargando…
Adipose-derived Mesenchymal Stem Cells Therapy as a new Treatment Option for Diabetes Mellitus
The worldwide increase in the prevalence of diabetes mellitus has raised the demand for new therapeutic strategies targeting diabetic symptoms and its chronic complications. Among different treatment options for diabetes, adipose-derived mesenchymal stem cells (ADMSCs) therapy attract the most atten...
Autores principales: | Mikłosz, Agnieszka, Chabowski, Adrian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348459/ https://www.ncbi.nlm.nih.gov/pubmed/36916961 http://dx.doi.org/10.1210/clinem/dgad142 |
Ejemplares similares
-
Using adipose‐derived mesenchymal stem cells to fight the metabolic complications of obesity: Where do we stand?
por: Mikłosz, Agnieszka, et al.
Publicado: (2022) -
Stem cell therapy for diabetes mellitus
por: Voltarelli, Júlio C, et al.
Publicado: (2011) -
Multivessel Coronary Artery Disease Complicated by Diabetes Mellitus Has a Relatively Small Effect on Endothelial and Lipoprotein Lipases Expression in the Human Atrial Myocardium and Coronary Perivascular Adipose Tissue
por: Knapp, Małgorzata, et al.
Publicado: (2023) -
Does TBC1D4 (AS160) or TBC1D1 Deficiency Affect the Expression of Fatty Acid Handling Proteins in the Adipocytes Differentiated from Human Adipose-Derived Mesenchymal Stem Cells (ADMSCs) Obtained from Subcutaneous and Visceral Fat Depots?
por: Mikłosz, Agnieszka, et al.
Publicado: (2021) -
Diabetes Mellitus in Neonates and Infants: Genetic Heterogeneity, Clinical Approach to Diagnosis, and Therapeutic Options
por: Rubio-Cabezas, Oscar, et al.
Publicado: (2013)